Tiziana life sciences to host kol webinar on foralumab in non-active secondary progressive multiple sclerosis (spms)

New york, may 25, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced it will host a virtual kol event to discuss the potential of foralumab in non-active secondary progressive multiple sclerosis (na spms) on monday, june 5, 2023 at 12:30 pm et.
TLSA Ratings Summary
TLSA Quant Ranking